...Sanofi (Euronext:SAN; NASDAQ:SNY) through its acquisition of Synthorx Inc....

...HER2-expressing solid tumors. CEO Laura Shawver joined the biotech this year, a few months after leading Synthorx Inc....

...“superkines,” and helped lay the groundwork for variations on the approach from  Nektar Therapeutics (NASDAQ:NKTR), Synthorx Inc....

...groups, through the pharma’s $2.5 billion acquisition of Synthorx...

...acquisition since it bought Ablynx N.V. for €3.9 billion in 2018. It paid $2.5 billion for Synthorx Inc....

...Inc. hired Enoch Kariuki as CFO, a new position. He was SVP, corporate development at Synthorx Inc....

...anti-PD-1 mAb Opdivo nivolumab from Bristol Myers Squibb Co. (NYSE:BMY) (see “Clever PEGylation Payoff” ). Synthorx Inc....

...their list price, and six of that group gained at least 300%: synthetic biology company Synthorx Inc....
...last December: Audentes, which was acquired by Astellas Pharma Inc. (Tokyo:4503) for $3 billion; and Synthorx...

...seek takeouts that bolster its innovative cancer pipeline. In January, Sanofi closed it acquisition of Synthorx Inc....

...succeeded by Joseph Leveque, who was hired as CMO; Leveque held the same role at Synthorx Inc....